Skip to main content

Table 3 Serum PLGF, sFlt-1 and sFlt-1/PLGF levels at 30-31+6 weeks of pregnancy

From: Discussion on the evaluation of the therapeutic efficacy of uterine artery blood flow parameters and serum PLGF and sFlt-1 in patients with recurrent spontaneous abortion

Group

Numbers

sFlt-1(ng/ml)

PLGF(ng/ml)

sFlt-1/PLGF

aspirin group

57

2234.71±888.80▲

371.86±175.01▲

7.59±4.75▲

combined drug group

63

2278.39±879.62▲

422.93±194.87▲

6.96±5.53▲

non-drug group

20

3262.38±941.48

175.57±50.47

20.24±8.09

control group

95

2215.95±737.58▲

366.43±162.48▲

7.91±5.44▲

  1. â–² indicates p < 0.05 compared to the non-drug group